Fundraising Fox
/People
Sign in

René Kuijten

Investor

Partner at EQT Life Sciences

Amsterdam, North Holland, Netherlands

Find your path to René

64 people in our graph can introduce you to René.

Sign up to see every warm intro you have to René

  • Paths you didn't know you had: your email and LinkedIn already hold routes to René. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

René Kuijten leads EQT Life Sciences and has been a Partner at EQT since 2022; he previously served as Managing Partner at LSP from 2001 until it merged with EQT and was renamed EQT Life Sciences. Before LSP, he spent eight years as a senior consultant at McKinsey & Company, where he co-led the European Healthcare Practice. He holds an MD from Utrecht University, a PhD from the University of Amsterdam based on research as a WHO fellow at the University of Pennsylvania, and an MBA from INSEAD.

Contact· self-published, not guessed

Invests in

BiotechHealthtechMedical Devices

Experience

  1. EQT GroupPartner at EQT | Head of EQT Life Sciencescurrent2001 — presentAmsterdam, Munich, Boston
  2. ArtiosSupervisory Board Membercurrent2018 — presentCambridge, England, United Kingdom
  3. Oncode InstituteVice-chairman Supervisory Board and Foundercurrent2012 — present
  4. Oncode AcceleratorSupervisory Board Member and Foundercurrent2022 — present
  5. Universiteit UtrechtChairman Utrechts Universiteitsfonds (U-fonds)current2026 — present
  6. Universiteit UtrechtJury member Agnites Vrolik Prize2018 — 2025
  7. Universiteit UtrechtInternational Advisory Board Utrecht Life Sciences (ULS)2017 — 2023
  8. Health~HollandAdvisory Board Topsector Life Sciences and Healthcurrent2011 — present
  9. Netherlands Academy of EngineeringFellowcurrent2023 — present
  10. Koninklijke Hollandsche Maatschappij der WetenschappenRoyal Dutch Society for Sciences and Humanitiescurrent2016 — present
  11. Gemeente AmsterdamFrans Banninck Cocqpenning2026
  12. Amsterdam UMCChairman Stichting Steun Emma Kinderziekenhuis2007 — 2023
  13. MenzisRaad van Advies2020 — 2022
  14. Vereniging RembrandtTreasurer2015 — 2021
  15. Nederlandse Vereniging van Participatiemaatschappijen (NVP)Management Board2007 — 2019Dutch Venture Capital & Private Equity Association
  16. Pivot ParkAdvisory Board science park Oss2013 — 2015
  17. Ministerie van OCWNetherlands Genomics Institute International Valorisation Advisory Board2008 — 2013
  18. McKinsey & CompanyAlumni Board and Max Geldens Stichting2001 — 2009
  19. New Venture NLJury business plan competition2001 — 2007
  20. KNAW - Koninklijke Nederlandse Akademie van WetenschappenCommissie Genoctrooien2003
  21. McKinsey&CompanySenior Management Consultant1992 — 2000Amsterdam, Zurich, Brussels
  22. World Health OrganizationFellow1988 — 1992Philadelphia

Skills & more

Venture Capital77Biotechnology14Lifesciences9Due Diligence16Private Equity42Venture Financing9Angel Investing9Corporate Development39Business Development5Pharmaceutical Industry6Entrepreneurship10Mergers2
+9 moreMergers & AcquisitionsStart-upsTechnology TransferCorporate FinanceInvestor RelationsCommercializationRestructuringGrowth CapitalLife Sciences

Languages Dutch · English · French · German

From René's professional profile.

Investments

Led

Neuravi

Investor

Artios PharmaBMEYENeuraviSyntaxin

Sources: the firm's website · curated public sources.

Colleagues at EQT Life Sciences

Alexandra Edlund
Chief People Officer at EQT Life Sciences
Andre Olijslager
Investor at LSP (Life Sciences Partners)
Anne Portwich
Partner at EQT Life Sciences
Anton Pijpers
Investor at LSP (Life Sciences Partners)
Arno de Wilde
Investor at EQT Life Sciences
Bas Vaessen
Investor at LSP (Life Sciences Partners)
Bert Janssens
Partner, Co-Head of Private Capital at EQT Life Sciences
Bruno Holthof
Partner at EQT Life Sciences

Frequently asked questions

Who is René Kuijten?
René Kuijten leads EQT Life Sciences and has been a Partner at EQT since 2022; he previously served as Managing Partner at LSP from 2001 until it merged with EQT and was renamed EQT Life Sciences. Before LSP, he spent eight years as a senior consultant at McKinsey & Company, where he co-led the European Healthcare Practice. He holds an MD from Utrecht University, a PhD from the University of Amsterdam based on research as a WHO fellow at the University of Pennsylvania, and an MBA from INSEAD.
Where does René Kuijten work?
René Kuijten is Partner at EQT Life Sciences.
What does René Kuijten invest in?
René Kuijten invests in Biotech, Healthtech, Medical Devices.
What companies has René Kuijten invested in?
Investments tracked here include Neuravi, Artios Pharma, BMEYE, Neuravi, Syntaxin.
Where did René Kuijten go to school?
René Kuijten studied at INSEAD (MBA, business administration); University of Amsterdam (Doctor of Philosophy (PhD), Oncology); Utrecht University (Doctor of Medicine (MD)).
Does René Kuijten lead rounds?
Yes — René Kuijten has led 1 tracked investment.

Same school

Shared employers

Also worked at Ministerie van OCW1

Elbert DijkgraafBestuurslid at Noaber